First Report of OS >5 Years in Metastatic Breast Cancer
There was over a 12-month improvement in median overall survival when the CDK 4/6 inhibitor ribocicl...
Denosumab Now Dominant Therapy for Cancer-Associated Osteoporosis
Amid a substantial expansion of therapies in sever...